| Time | Topic |
|---|---|
| 7:00 a.m. | Registration & Continental Breakfast |
| 7:45 a.m. | Welcome and Pre-test Barbara A. Pockaj, M.D. |
| 8:00 a.m. | Melanoma Risk Factors James B. MacDonald, M.D. |
| 8:20 a.m. | Hereditary Cancer Syndromes Associated With Malignant Melanoma Katherine S. Hunt, MS, CGC |
| 8:50 a.m. | Dermatology and Tele-medicine James A. Yiannias, M.D. |
| 9:05 a.m. | Tricks for Closure for Anatomically Challenged Melanomas Shari A. Nemeth, M.D. |
| 9:25 a.m. | Panel Discussion Session Faculty |
| 9:45 a.m. | Break |
| 10:00 a.m. | Melanoma Pathology Report: Which Features Should You Worry About Lori A. Erickson, M.D. |
| 10:20 a.m. | Personalized Medicine in Melanoma: Focusing on Molecular Targets Aleksandar Sekulic, M.D., Ph.D. |
| 10:50 a.m. | The Other "Bad" Skin Cancers: Merkel Cell, Etc. Barbara A. Pockaj, M.D. |
| 11:10 a.m. | Panel Discussion Session Faculty |
| 11:30 a.m. | Lunch (included) |
| 12:30 p.m. | Use of PET/CT in Evaluation of Melanoma Patients Michael C. Roarke, M.D. |
| 12:50 p.m. | Controversies in the Surgical Management Of Melanoma Sanjay P. Bagaria, M.D. |
| 1:10 p.m. | Management Options for Local Recurrence and In-transit Metastasis in Cutaneous Melanoma Richard J. Gray, M.D. |
| 1:30 p.m. | Panel Discussion Session Faculty |
| 1:45 p.m. | Break |
| 2:00 p.m. | Immunotherapy for Malignant Melanoma Richard W. Joseph, M.D. |
| 2:30 p.m. | Targeted Therapy for Malignant Melanoma Alan H. Bryce, M.D. |
| 3:00 p.m. | Therapy for Advanced BCC Aleksandar Sekulic, M.D., Ph.D. |
| 3:20 p.m. | Panel Discussion Session Faculty |
| 3:35 p.m. | Cases and Post-test Barbara A. Pockaj, M.D. |
